Target N V Biotech's Net Worth
Target N V Biotech's net worth is estimated to be at least $125,624,708.12 as of 11/23/2024. CoreStreet's estimation of Target N V Biotech's net worth is based on their sale of stock and current holding of stock.
Target N V Biotech is Major Shareholder at Molecular Templates Inc. They have executed at least 60 trades of stock as per SEC Form 4 filings. Their most recent trade was for 250,000 units of MTEM stock on 04/02/2024. Their biggest sale was on when they sold units of stock for $. They typically trade 7 times per year.
Total value of insider buys:
- $125,624,708.12
Total value of insider sells:
- $0.00
Most recent insider trade:
- April 2, 2024
Target N V Biotech's Insider Trading History
Molecular Templates Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
April 2, 2024 | Major Shareholder | 250,000 | $2.35 | Buy | $587,500.00 |
July 17, 2023 | Major Shareholder | 4,255,319 | $0.47 | Buy | $1,999,999.93 |
May 16, 2022 | Major Shareholder | 200,000 | $1.18 | Buy | $236,000.00 |
Jan. 6, 2022 | Major Shareholder | 200,000 | $4.04 | Buy | $808,000.00 |
Sept. 21, 2021 | Major Shareholder | 750,000 | $6.00 | Buy | $4,500,000.00 |
Sept. 16, 2021 | Major Shareholder | 100,000 | $6.13 | Buy | $613,000.00 |
July 26, 2021 | Major Shareholder | 80,000 | $7.00 | Buy | $560,000.00 |
July 19, 2021 | Major Shareholder | 119,382 | $6.96 | Buy | $830,898.72 |
April 19, 2021 | Major Shareholder | 40,852 | $8.08 | Buy | $330,084.16 |
April 14, 2021 | Major Shareholder | 150,000 | $8.37 | Buy | $1,255,500.00 |
April 12, 2021 | Major Shareholder | 50,000 | $8.02 | Buy | $401,000.00 |
April 8, 2021 | Major Shareholder | 500,000 | $8.23 | Buy | $4,115,000.00 |
April 5, 2021 | Major Shareholder | 200,000 | $9.44 | Buy | $1,888,000.00 |
March 29, 2021 | Major Shareholder | 80,000 | $11.45 | Buy | $916,000.00 |
Feb. 23, 2021 | Major Shareholder | 235,004 | $11.29 | Buy | $2,653,195.16 |
Feb. 18, 2021 | Major Shareholder | 1,185,770 | $12.65 | Buy | $14,999,990.50 |
Feb. 1, 2021 | Major Shareholder | 80,000 | $11.69 | Buy | $935,200.00 |
Jan. 29, 2021 | Major Shareholder | 80,000 | $11.94 | Buy | $955,200.00 |
Dec. 9, 2020 | Major Shareholder | 125,000 | $8.62 | Buy | $1,077,500.00 |
Nov. 9, 2020 | Major Shareholder | 80,000 | $9.05 | Buy | $724,000.00 |
Nov. 5, 2020 | Major Shareholder | 75,000 | $10.86 | Buy | $814,500.00 |
MacroGenics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Oct. 2, 2023 | Major Shareholder | 150,000 | $4.46 | Buy | $669,000.00 |
Sept. 7, 2023 | Major Shareholder | 200,000 | $5.26 | Buy | $1,052,000.00 |
Feb. 14, 2023 | Major Shareholder | 500,000 | $5.07 | Buy | $2,535,000.00 |
Jan. 19, 2023 | Major Shareholder | 150,000 | $5.30 | Buy | $795,000.00 |
Dec. 27, 2022 | Major Shareholder | 200,000 | $5.61 | Buy | $1,122,000.00 |
Dec. 23, 2022 | Major Shareholder | 200,000 | $5.88 | Buy | $1,176,000.00 |
Nov. 22, 2022 | Major Shareholder | 300,000 | $5.96 | Buy | $1,788,000.00 |
Oct. 24, 2022 | Major Shareholder | 250,000 | $4.36 | Buy | $1,090,000.00 |
Oct. 21, 2022 | Major Shareholder | 250,000 | $4.63 | Buy | $1,157,500.00 |
Oct. 19, 2022 | Major Shareholder | 168,422 | $3.70 | Buy | $623,161.40 |
Nov. 19, 2021 | Major Shareholder | 200,000 | $18.50 | Buy | $3,700,000.00 |
Sept. 28, 2021 | Major Shareholder | 100,000 | $20.64 | Buy | $2,064,000.00 |
Sept. 16, 2021 | Major Shareholder | 400,000 | $20.94 | Buy | $8,376,000.00 |
June 15, 2021 | Major Shareholder | 75,000 | $20.53 | Buy | $1,539,750.00 |
Radius Heal | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
May 18, 2022 | Major Shareholder | 477,824 | $5.57 | Buy | $2,661,479.68 |
Jan. 5, 2022 | Major Shareholder | 250,000 | $6.30 | Buy | $1,575,000.00 |
Sept. 29, 2021 | Major Shareholder | 100,000 | $12.95 | Buy | $1,295,000.00 |
Sept. 22, 2021 | Major Shareholder | 150,000 | $12.28 | Buy | $1,842,000.00 |
Sept. 14, 2020 | Major Shareholder | 200,000 | $11.69 | Buy | $2,338,000.00 |
Sept. 11, 2020 | Major Shareholder | 199,029 | $11.33 | Buy | $2,254,998.57 |
July 8, 2020 | Major Shareholder | 25,000 | $13.21 | Buy | $330,250.00 |
Esperion Th | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
May 19, 2021 | Major Shareholder | 200,000 | $20.37 | Buy | $4,074,000.00 |
Jan. 23, 2020 | Major Shareholder | 20,000 | $51.84 | Buy | $1,036,800.00 |
Nov. 6, 2019 | Major Shareholder | 75,000 | $37.30 | Buy | $2,797,500.00 |
Sept. 4, 2019 | Major Shareholder | 80,000 | $33.78 | Buy | $2,702,400.00 |
July 23, 2019 | Major Shareholder | 50,000 | $42.65 | Buy | $2,132,500.00 |
March 14, 2019 | Major Shareholder | 50,000 | $49.89 | Buy | $2,494,500.00 |
Jan. 4, 2019 | Major Shareholder | 80,000 | $41.29 | Buy | $3,303,200.00 |
Dec. 24, 2018 | Major Shareholder | 50,000 | $39.91 | Buy | $1,995,500.00 |
Dec. 17, 2018 | Major Shareholder | 60,000 | $47.73 | Buy | $2,863,800.00 |
Aug. 3, 2018 | Major Shareholder | 50,000 | $46.14 | Buy | $2,307,000.00 |
July 12, 2018 | Major Shareholder | 50,000 | $41.77 | Buy | $2,088,500.00 |
June 29, 2018 | Major Shareholder | 50,000 | $39.48 | Buy | $1,974,000.00 |
June 21, 2018 | Major Shareholder | 60,000 | $38.57 | Buy | $2,314,200.00 |
June 7, 2018 | Major Shareholder | 60,000 | $37.79 | Buy | $2,267,400.00 |
June 5, 2018 | Major Shareholder | 60,000 | $38.47 | Buy | $2,308,200.00 |
May 21, 2018 | Major Shareholder | 130,000 | $40.11 | Buy | $5,214,300.00 |
May 18, 2018 | Major Shareholder | 50,000 | $42.24 | Buy | $2,112,000.00 |
Cidara Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Nov. 15, 2017 | Major Shareholder | 60,000 | $7.57 | Buy | $454,200.00 |